Results 151 to 160 of about 129,162 (296)

Large language models for bioinformatics

open access: yesQuantitative Biology, Volume 14, Issue 1, March 2026.
Abstract With the rapid advancements in large language model technology and the emergence of bioinformatics‐specific language models (BioLMs), there is a growing need for a comprehensive analysis of the current landscape, computational characteristics, and diverse applications.
Wei Ruan   +54 more
wiley   +1 more source

Patterns of Dysgraphia in Primary Progressive Aphasia Compared to Post-Stroke Aphasia

open access: yesBehavioural Neurology, 2013
We report patterns of dysgraphia in participants with primary progressive aphasia that can be explained by assuming disruption of one or more cognitive processes or representations in the complex process of spelling.
Andreia V. Faria   +7 more
doaj   +1 more source

Impaired phonemic discrimination in logopenic variant primary progressive aphasia [PDF]

open access: gold, 2020
Jeremy C. S. Johnson   +13 more
openalex   +1 more source

A STOP‐Gain RNF213 Variant Causes Chorea, Stroke‐Like Episodes, and Leigh Syndrome‐Like Encephalopathy

open access: yes
Movement Disorders, EarlyView.
Roberta Bovenzi   +8 more
wiley   +1 more source

Relationship between age and severity of cognitive impairment at diagnosis for early‐onset and late‐onset Alzheimer's disease: Comparison of LEADS and ADNI

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
INTRODUCTION Recent work has identified unique cognitive profiles for early‐onset Alzheimer's disease (EOAD) relative to late‐onset Alzheimer's disease (LOAD), however, examination has been limited in determining whether the association between age and cognitive severity at presentation also differs across conditions.
Dustin B. Hammers   +40 more
wiley   +1 more source

Urinary tract infection‐related delirium in Alzheimer's disease and related dementias: Clinical challenges and translational opportunities

open access: yesAlzheimer's &Dementia, Volume 22, Issue 2, February 2026.
Abstract Alzheimer's disease and related dementias (ADRD) affects millions of patients worldwide and is a leading cause of morbidity in older adults. Patients with ADRD are particularly susceptible to developing urinary tract infection (UTI) and UTI‐related delirium, creating a self‐perpetuating cycle in which ADRD increases vulnerability to infection ...
Sarah Kim   +3 more
wiley   +1 more source

Bispecific Antibodies Versus Chimeric Antigen Receptor T‐Cell Therapy in Relapsed/Refractory Diffuse Large B‐Cell Lymphoma: A Comparative Narrative Review of Efficacy, Safety, and Accessibility

open access: yesCancer Medicine, Volume 15, Issue 2, February 2026.
ABSTRACT Introduction Diffuse large B‐cell lymphoma (DLBCL) is the most common subtype of non‐Hodgkin lymphoma, and despite advances in frontline therapies such as rituximab, cyclophosphamide, doxorubicin hydrochloride (hydroxydaunorubicin), vincristine sulfate (Oncovin), and prednisone, approximately 30%–40% of patients develop relapsed or refractory (
Dana Sofian Abou   +6 more
wiley   +1 more source

Linking Attention Deficits to Difficulties in the Comprehension of Complex Syntax in Dyslexia

open access: yesDyslexia, Volume 32, Issue 1, February 2026.
ABSTRACT Recent research suggests that dyslexia involves not only reading difficulties but also deficits in working memory, attention, language, and information processing. This study examined the role of auditory attention in the comprehension of syntactically complex sentences in children with dyslexia.
Mostafa Mazlumi, Mehdi Purmohammad
wiley   +1 more source

Healthy brain connectivity predicts atrophy progression in non-fluent variant of primary progressive aphasia [PDF]

open access: bronze, 2016
Maria Luisa Mandelli   +15 more
openalex   +1 more source

T‐Cell–Redirecting Immunotherapies in Relapsed/Refractory Mantle Cell Lymphoma: Current Evidence, Sequencing, and Future Directions

open access: yesEuropean Journal of Haematology, Volume 116, Issue 2, Page 129-141, February 2026.
ABSTRACT Relapsed/refractory (R/R) mantle cell lymphoma (MCL) remains a therapeutic challenge, particularly in patients with high‐risk features or prior exposure to Bruton's tyrosine kinase inhibitors (BTKis). The advent of T‐cell–redirecting immunotherapies, including chimeric antigen receptor T‐cell (CAR‐T) therapy and bispecific antibodies (BsAbs ...
Santino Caserta   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy